Century Therapeutics, Inc

📍 Philadelphia, United States🗓 Founded 2018👥 188 employees💰 Last funded Oct 2022
Biotechnology🌐 centurytx.com
Website LinkedIn
Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care. Please note Century Therapeutics does not solicit prospective Colleagues directly via Telegram (or other social media sites), or require potential candidates to make purchases of goods or services.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Century Therapeutics, Inc?
Century Therapeutics, Inc has 1 investors on record on gritt.io, 1 mid-stage.
When did Century Therapeutics, Inc last raise funding?
The most recent investment in Century Therapeutics, Inc recorded on gritt.io was in October 2022.
When was Century Therapeutics, Inc founded?
Century Therapeutics, Inc was founded in 2018.
What industry is Century Therapeutics, Inc in?
Century Therapeutics, Inc operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Century Therapeutics, Inc based?
Century Therapeutics, Inc is headquartered in Philadelphia, United States.